Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

J&J Didn’t Warn Levaquin Riskier Than Rivals, Lawyer Argues
Bloomberg
Thursday, October 13, 2011 - 10:53am
tags:
JNJ, antibiotics, Levaquin, Ortho-McNeil-Janssen
Positive Data on Forest Candidate
Yahoo/Zacks.com
Thursday, October 13, 2011 - 10:52am
tags:
Forest Labs, antipsychotics, Bristol-Myers Squibb, Eli Lilly, cariprazine
FDA green lights improved inhaler for Boehringer COPD drug
Fierce Drug Delivery
Wednesday, October 12, 2011 - 10:52am
tags:
FDA, COPD, Combivent Respimat, Boehringer Ingelheim
Teva's Copaxone reduced brain volume loss in patients, according to study
Drugstore News
Wednesday, October 12, 2011 - 10:51am
tags:
Copaxone, Teva Pharmaceuticals, MS, multiple sclerosis
Dendreon to amp up DTC support for Provenge
Fierce Pharma
Wednesday, October 12, 2011 - 10:43am
tags:
DTC, Provenge, prostate cancer, Dendreon
8 Biotech Stocks Seeing Bearish Options Sentiment
Seeking Alpha
Wednesday, October 12, 2011 - 10:42am
tags:
Acorda, Cytori, Indenix, Vical, Medivation, Optimer Pharmaceuticals, Vertex Pharmaceuticals, XenoPort
AMAG Board Says Shareholders Should Vote for Allos Purchase
Bloomberg
Wednesday, October 12, 2011 - 10:41am
tags:
M&A, Allos, Amag Pharmaceuticals
Pfizer Settles Norplant Lawsuits For $29.5 Million
Pharmalot
Wednesday, October 12, 2011 - 9:28am
tags:
Norplant, Pfizer, settlements
Pfizer Tries to Block Merck Lipitor-Zetia Pill
WSJ Online
Wednesday, October 12, 2011 - 9:27am
tags:
Merck, Pfizer, Lipitor, Zetia, generics
Good Sign For Cytori Therapeutics: Athletes Seek Out Stem Cell Therapy
Seeking Alpha
Wednesday, October 12, 2011 - 9:25am
tags:
Cytori, stem cells
Onyx Pharmaceuticals extends oncology working relationship with Bayer
Yahoo/AP
Wednesday, October 12, 2011 - 9:25am
tags:
Bayer, ONYX Pharmaceuticals, regorafenib
The Medicines Company Needs More Options Beyond Angiomax
Bloomberg
Wednesday, October 12, 2011 - 9:23am
tags:
Angiomax, Medicines Company, Teva Pharmaceuticals
Merck’s Australian Unit Wins Bid to Overturn Trial Decision on Vioxx Drug
Bloomberg
Wednesday, October 12, 2011 - 9:21am
tags:
Merck, Australia, Vioxx
Dividend Leaders Abbott, Baxter See Q3 EPS Growth
Investors.com
Wednesday, October 12, 2011 - 9:20am
tags:
earnings, dividends, Abbott Laboratories, Baxter
Seattle Genetics: Weighing Bearish And Bullish Opinions
Seeking Alpha
Tuesday, October 11, 2011 - 5:16pm
tags:
Seattle Genetics, Immunogen
AstraZeneca Loves This $100Bn Market
Motley Fool
Tuesday, October 11, 2011 - 5:14pm
tags:
AstraZeneca, China
BioSante Rising as Female Libido Drug Moves Foward
Minyanville
Tuesday, October 11, 2011 - 5:13pm
tags:
female sexual dysfunction, BioSante, LibiGel
GlaxoSmithKline grants will fund melanoma drug research
Bizjournals.com
Tuesday, October 11, 2011 - 5:11pm
tags:
GSK, melanoma, grants
Agios and Celgene: Anatomy of an Ultra-Valuable Biotech Marriage
Motley Fool
Tuesday, October 11, 2011 - 11:23am
tags:
Agios, Celgene, drug development, cancer
Sanofi's Viehbacher sees green lights ahead for Shantha
Fierce Pharma Manufacturing
Tuesday, October 11, 2011 - 11:22am
tags:
Sanofi, drug manufacturing, Shantha Biotech, Shanchol, Chris Viehbacher

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.